Leishmaniasis is a complex disease with cutaneous, mucocutaneous, or visceral manifestations depending on the parasite species and host immunity. Despite continued elimination efforts, leishmaniasis continues to afflict known and newer endemic regions, where 0.5--0.9 million new cases of visceral leishmaniasis (VL) and 0.6--1.0 million new cases of cutaneous leishmaniasis (CL) occur every year ([@R1]). An increase in VL and CL cases from newer foci and atypical disease manifestation pose a challenge to leishmaniasis control programs ([@R2]--[@R7]). Unlike the known species-specific disease phenotype, parasite variants can cause atypical disease, so that *Leishmania* species generally associated with VL can cause CL and vice versa.

In India, VL caused by *L. donovani* parasites in the northeastern region and CL caused by *L. tropica* in the western Thar Desert represent the prevalent forms of the disease ([@R2]). Himachal Pradesh is a more recently leishmaniasis-endemic state in northwest where VL and CL coexist; CL incidence is higher than VL incidence and most cases are attributable to *L. donovani* instead of *L. tropica* infection ([@R8],[@R9]). Sharma et al. conducted limited molecular analysis of a few CL cases and reported preliminary findings ([@R8]). For an in-depth study on the involvement of *L. donovani* parasites in CL cases, we conducted a comprehensive molecular analysis of CL cases in Himachal Pradesh.

The Study
=========

During 2014--2018, an increase in CL cases occurred in Himachal Pradesh; case reports came from different tehsils (i.e., townships) in Kinnaur, Shimla, and Kullu and the previously nonendemic districts of Mandi and Solan ([Appendix](#SD1){ref-type="local-data"} Table 1, Figure 1). We confirmed 60 CL cases indigenous to the state with detailed patient information, demonstration of the presence of Leishman-Donovan bodies and CL-specific histopathologic changes in skin lesional specimens, and PCR detection of parasitic infection (Appendix).

We conducted PCR and restriction fragment-length polymorphism (RFLP) analysis of parasite species--specific internal transcribed spacer 1 (ITS1) sequences by using appropriate standard controls. We detected the expected ≈320-bp product with a *Hae*III RFLP pattern specific to *L. donovani* complex in all patient biopsy specimens, indicating *L. donovani*, *L. infantum,* or both as the causative agent of infection ([Appendix](#SD1){ref-type="local-data"} Figure 4) ([@R10]).

BLAST analysis (<https://blast.ncbi.nlm.nih.gov/Blast.cgi>) of 44 ITS1 test sequences showed all the samples to be closest to *L. donovani*, having maximum identity to *L. donovani* isolates from Bhutan (GenBank accession nos. JQ730001--2) and possibly *L. infantum*. None of the CL cases were consistent with *L. tropica* infection, unlike in a previous report ([@R8]). To distinguish whether HP isolates were *L. donovani*, *L. infantum*, or both and to infer genetic and geographic relatedness between these isolates and standard reference strains, we performed ITS1 microsatellite repeat analysis and phylogenetic classification ([@R11]--[@R13]). The 4 ITS1 polymorphic microsatellite repeat analysis indicate HP isolates different from *L. infantum* and closest to the *L. donovani* isolates from Bhutan ([Table 1](#T1){ref-type="table"}; [Figure 1](#F1){ref-type="fig"}, panel A). We detected a polymorphism in the third poly (TA) microsatellite locus with 5 repeats and an atypical insert of TAA and the fourth poly (A) microsatellite tract with 8 repeats; these polymorphisms were identical to the VL-causing *L. donovani* isolates from Bhutan. An *L. donovani* Chandigarh isolate originally from HP is reported to be closest to the Bhutan isolates and matched with HP isolates at the third poly (TA) stretch ([@R12]). However, Himachal Pradesh isolates were distinct at the first poly C and the second poly A microsatellite tracts and had heterogeneous base sequences. Thus, these isolates represent *L. donovani* genetic variants; none showed the ITS1 sequence type previously assigned to the referred *L. donovani* isolates by Kuhls et al. ([@R13]). Our phylogenetic analysis of 44 ITS1 test sequences and ITS1 reference sequences placed all the CL-causing *L. donovani* isolates from Himachal Pradesh into a discrete cluster different from the VL-causing *L. donovani* from India and elsewhere and the CL-causing *L. donovani* isolates from Sri Lanka. The Himachal Pradesh CL isolates within the cluster exhibited considerable heterogeneity ([Table 1](#T1){ref-type="table"}; [Figure 1](#F1){ref-type="fig"}, panel B; [Appendix](#SD1){ref-type="local-data"} Table 4).

###### Standard *Leishmania* strains used in ITS1-based microsatellite polymorphism and phylogenetic analysis of cutaneous leishmaniasis isolates, Himachal Pradesh, India, 2014--2018\*

  Standard *Leishmania* strains (place of origin)                       WHO code                 Genbank accession no.   Zymodeme   Disease form   Strain type†   ITS1 polymorphic microsatellite stretches (nucleotide position, bp)                           
  --------------------------------------------------------------------- ------------------------ ----------------------- ---------- -------------- -------------- --------------------------------------------------------------------- ----------- ----------- --------
  VL- and CL-causing *L. infantum* and *L. donovani* parasite strains                                                                                                                                                                                           
  *L. infantum* (Tunisia)                                               MHOM/TN/80/IPT1          AJ000289                MON-1      VL             A              3                                                                     6           4           8
  *L. donovani* (India)                                                 MHOM/IN/00/DEVI          AJ634376                MON-2      VL             H              2                                                                     8           5           7
  *L. donovani*   (Sri Lanka)                                           MHOM/LK/2002/ L60c       AM901447                MON-37     CL             ND             2                                                                     8           5           7
  *L. donovani*   (Bangladesh)                                          ND                       KT921417                ND         VL             ND             2                                                                     8           5           7
  *L. donovani* (Kenya)                                                 MHOM/KE/85/ NLB323       AJ000297                MON-37     VL             G              2                                                                     8           5           7
  *L. donovani* (Sudan)                                                 MHOM/SD/75/ LV139        AJ000291                ND         CL             E              2                                                                     8           6           8
  MHOM/SD/93/9S                                                         AJ634372                 MON-18                  VL         F              2              9                                                                     5           7           
  *L. donovani* (Ethiopia)                                              MHOM/ET/67/HU3           AJ634373                MON-18     VL             F              2                                                                     9           5           7
  *L. donovani* (China)                                                 MHOM/CN/00/ Wangjie1     AJ000294                MON-35     VL             C              3                                                                     6           4           7
  *L. donovani*   (HP, India)                                           MHOM/IN/83/ CHANDIGARH   AM901449                MON-37     VL             ND             2                                                                     8           2, TAA, 3   7
  *L. donovani* (Bhutan)                                                Trashigang1              JQ730001                ND         VL             ND             2                                                                     8           2, TAA, 3   8
  Samtse1                                                               JQ730002                 ND                      VL         ND             2              9                                                                     2, TAA, 3   8           
  CL-causing *L. donovani* isolates from Himachal Pradesh‡                                                                                                                                                                                                      
  HPCL22                                                                --                       MG982955                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL27                                                                --                       MG982958                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL28                                                                --                       MG982959                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL32                                                                --                       MG982963                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL42                                                                --                       MG982972                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL45                                                                --                       MG982975                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL47                                                                --                       MG982977                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL49                                                                --                       MG982978                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL52                                                                --                       MG982981                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  HPCL55                                                                --                       MG982983                ND         CL             ND             Heterogeneous                                                         2, TAA, 3   8           
  CL-causing standard WHO *Leishmania* species                                                                                                                                                                                                                  
  *L. major*                                                            MHOM/SU/73/ 5ASKH        AJ000310                MON-4      CL             ND             4                                                                     6           6           6
  *L. tropica*                                                          MHOM/SU/60/OD            EU326226                LON-7      CL             ND             4                                                                     9           1, TTA, 2   3,C,4A
  *L. mexicana*                                                         MHOM/MX/85/ SOLIS        AJ000313                MON-152    CL             ND             2                                                                     8           1,          3,C,7A
  *L. braziliensis*                                                     MHOM/BR/00/ LTB300       FN398338                MON-166    CL             ND             2                                                                     6           1           5
  *L. amazonensis*                                                      MHOM/BR/73/ M2269        HG512964                MON-132    CL             ND             2                                                                     7           1           3,C,6A

\*CL, cutaneous leishmaniasis; HP, Himachal Pradesh; ITS1, internal transcribed spacer 1; ND, not determined; VL, visceral leishmaniasis; WHO, World Health Organization. †ITS sequences strain type according to Kuhls et al. (*13*). ‡These species represent 10/44 samples used in polymorphic microsatellite analysis.

![ITS1-based molecular analysis of clinical isolates from cutaneous leishmaniasis (CL) patients, Himachal Pradesh, India, 2014--2018. A) Multiple sequence alignment of ITS1 microsatellite repeat sequences of representative parasite isolates from CL patients with those of *L. donovani* complex reference strains from different geographic regions. Sequences were aligned by using BioEdit sequence alignment program (<https://bioedit.software.informer.com/7.2>). B) Phylogenetic tree of ITS1 sequences from CL test isolates (designated as HPCL, numbered in order of their collection) and standard *Leishmania* strains. Tree constructed by using maximum-likelihood method with 5,000 bootstraps in the *dnaml* program of PHYLIP package (<http://evolution.genetics.washington.edu/phylip/doc/main.html>). GenBank accession numbers are indicated. Scale bar indicates the nucleotide substitution per site. ITS1, internal transcribed spacer 1; RFLP, restriction fragment length polymorphism.](19-1761-F1){#F1}

Sequences of the 6-phosphogluconate dehydrogenase gene (6PGDH) exhibit a high degree of polymorphism and have been used to identify *Leishmania* species and differentiate region-specific zymodemes ([@R14]). We performed multiple sequence alignment of the representative partial 6PGDH amino acid sequences from Himachal Pradesh isolates by using the homologous 6PGDH protein sequences of the reference *Leishmania* isolates to determine their genetic and geographic relatedness ([Table 2](#T2){ref-type="table"}; [Figure 2](#F2){ref-type="fig"}, panel A; [Appendix](#SD1){ref-type="local-data"} Table 4, Figure 5). Himachal Pradesh isolates exhibited a 6PGDH sequence specific to Mon-37 and different from Mon-2 (having aspartic acid in place of asparagine) at position 326 ([Figure 2](#F2){ref-type="fig"}, panel A). Thus, CL-causing *L. donovani* from Himachal Pradesh were distinct from the most common VL-causing India Mon-2 *L. donovani* and the Bangladesh *L. donovani* isolate, whereas they were similar to the CL-causing *L. donovani* isolate from Kerala and CL- and VL-causing Mon-37 isolates from Sri Lanka and the isolates from Kenya, Brazil, and China.

###### Standard *Leishmania* strains used in partial 6PGDH amino acid--based phylogenetic analysis of cutaneous leishmaniasis isolates, Himachal Pradesh, India, 2014--2018\*

  Species (place of origin)       WHO code                Zymodeme   GenBank accession no.   Pathology
  ------------------------------- ----------------------- ---------- ----------------------- -----------
  WHO standards                                                                              
  *L. donovani* (India)           MHOM/IN/0000/DEVI       MON-2      AM157147                VL
  *L. major* (Turkmenistan)       MHOM/TM/1973/5ASKH      ND         AY706107                CL
  *L. infantum*                   ND                      ND         XM_001469106            ND
  *L. mexicana*                   MHOM/BZ/82/BEL21        ND         AY386372                CL
  *L. tropica*                    ND                      ND         AY045763                CL
  *L. amazonensis*                ND                      ND         AY168562                CL
  Regional standards                                                                         
  *L. donovani* (China)           MHOM/CN/90/9044         ND         JX021389                VL
  *L. donovani* (Kenya)           IMAR/KE/1962/LRC--L57   MON-37     AJ888902                ND
  *L. donovani* (Sri Lanka)       MHOM/LK/2010/OVN3       MON-37     JX481773                VL
  *L. donovani* (Sri Lanka)       MHOM/LK/2002/L59        MON-37     AJ888888                CL
  *L. donovani* (Bangladesh)      MHOM/BD/1997/BG1        ND         AJ888899                VL
  *L. donovani* (Brazil)          ND                      ND         AY168567                ND
  *L. donovani* (Kerala, India)   ND                      ND         KJ461872                CL

\*6PGDH, 6-phosphogluconate dehydrogenase gene; CL, cutaneous leishmaniasis; ND, not determined; VL, visceral leishmaniasis; WHO, World Health Organization.

![6PGDH-based molecular analysis of clinical isolates from cutaneous leishmaniasis (CL) patients, Himachal Pradesh, India, 2014--2018. A) Sequence alignment of partial 6PGDH amino acid of CL isolates exhibit replacement of asparagine (N) with aspartic acid (D) at position 326 analogous to visceral leishmaniasis--causing and CL-causing isolates from Sri Lanka. B) Phylogenetic tree for 6PGDH sequences from CL test isolates (designated as HPCL, numbered in order of their collection) and standard *Leishmania* strains. Tree constructed by using maximum-likelihood method with 5,000 bootstraps in the *dnam*l program of PHYLIP package (<http://evolution.genetics.washington.edu/phylip/doc/main.html>). GenBank accession numbers are indicated. Scale bar indicates the amino acid substitution per site. 6PGDH, 6-phosphogluconate dehydrogenase gene; HP, Himachal Pradesh.](19-1761-F2){#F2}

Phylogenetic analysis of 6PGDH amino acid sequences of CL isolates grouped them into a heterogeneous cluster; variants were closer to a viserotropic *L. donovani* isolate from Sri Lanka and distinct from the VL-causing *L. donovani* isolates from India and Bangladesh and CL-causing isolates from Kerala and Sri Lanka ([Figure 2](#F2){ref-type="fig"}, panel B). However, the HPCL55 isolate (GenBank accession no. MH208450) grouped differently. The HPCL49 isolate (GenBank accession no. MH208446) showed relatedness to the standard *L. infantum* strain, although ITS1 analysis using BLAST and microsatellite repeat sequences showed regions of similarity with *L. donovani*. ITS1 and 6PGDH sequence analysis suggest that Himachal Pradesh isolates from CL patients consist of heterogenous *L. donovani* variants and possibly represent hybrid genotypes.

None of the CL patients had VL-specific symptoms or VL history. Ten of 43 patient blood samples tested positive for rK39 antibody, and 37 of 51 samples were positive for the circulating parasite DNA with *L. donovani*--specific ITS1 ([Appendix](#SD1){ref-type="local-data"} Figure 6, panel A, B). The result suggests asymptomatic systemic *L. donovani* infection in a fraction of CL patients.

Conclusions
===========

The presence of leishmaniasis in Himachal Pradesh is not yet well known in India and globally ([@R15]). Our epidemiologic study shows newer CL pockets during 2014--2018; thus, the state needs to be recognized as leishmaniasis-endemic by public health authorities ([Appendix](#SD1){ref-type="local-data"} Figure 1). We conclude that CL cases in Himachal Pradesh are caused by *L. donovani* variants distinct from the viscerotropic *L. donovani* strain from northeast India. The CL isolates in Himachal Pradesh exhibit considerable heterogeneity and indicate the possible existence of genetic hybrids. The scenario appears somewhat similar to Sri Lanka and Kerala, where *L. donovani* parasites cause cutaneous disease, albeit with differences in the region-specific *L. donovani* variants. In lieu of the coexistence of VL and CL in Himachal Pradesh, parasite isolates from VL patients also need to be characterized. To understand the biology of atypical *L. donovani* variants with cutaneous manifestations and to genetically differentiate the dermotropic versus viscerotropic potential of *L. donovani* variants, comparison of CL- and VL-causing isolates in Himachal Pradesh using whole-genome sequence analysis is required.

*L. donovani* parasites in the blood of some CL patients represent human reservoirs similar to asymptomatic VL carriers, and the parasite variants have the potential to cause full-blown VL manifestations. An elaborate surveillance program dedicated to the Himachal Pradesh region is urgently required for better diagnosis, treatment, prediction of parasite variants in different afflicted pockets, and prevention of transmission of the disease to other regions.

###### Appendix

Additional information about *Leishmania donovani* infection with atypical cutaneous manifestations, Himachal Pradesh, India, 2014--2018.
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